Dr. Barry Wendt, MD

NPI: 1801888177
Total Payments
$4,013
2024 Payments
$1,203
Companies
38
Transactions
138
Medicare Patients
5,166
Medicare Billing
$243,487

Payment Breakdown by Category

Food & Beverage$4,013 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,013 138 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $566.47 8 $0 (2020)
ABBVIE INC. $552.55 24 $0 (2024)
Amgen Inc. $506.47 18 $0 (2024)
AstraZeneca Pharmaceuticals LP $476.89 7 $0 (2024)
Novo Nordisk Inc $264.93 11 $0 (2024)
PFIZER INC. $242.59 11 $0 (2024)
Exact Sciences Corporation $200.63 5 $0 (2024)
Astellas Pharma US Inc $148.70 3 $0 (2024)
Boston Scientific Corporation $145.35 4 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $119.30 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,203 37 Amgen Inc. ($345.18)
2023 $723.79 25 AbbVie Inc. ($143.64)
2022 $433.01 17 AstraZeneca Pharmaceuticals LP ($94.42)
2021 $224.30 15 AbbVie Inc. ($94.22)
2020 $161.51 7 E.R. Squibb & Sons, L.L.C. ($77.24)
2019 $504.48 21 E.R. Squibb & Sons, L.L.C. ($184.32)
2018 $474.03 7 E.R. Squibb & Sons, L.L.C. ($223.61)
2017 $289.07 9 PFIZER INC. ($118.59)

All Payment Transactions

138 individual payment records from CMS Open Payments — Page 6 of 6

Date Company Product Nature Form Amount Type
08/22/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $107.12 General
Category: Cardiovascular
05/15/2018 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $112.36 General
Category: Diabetes
03/01/2018 Boston Scientific Corporation WATCHMAN (Device) Food and Beverage In-kind items and services $110.56 General
Category: STRUCTURAL HEART
02/08/2018 Boston Scientific Corporation WATCHMAN (Device) Food and Beverage In-kind items and services $4.44 General
Category: STRUCTURAL HEART
10/19/2017 Merck Sharp & Dohme Corporation PNEUMOVAX 23 (Biological), GARDASIL9 Food and Beverage In-kind items and services $16.69 General
Category: VACCINE
10/09/2017 Respiratory Technologies, Inc. Food and Beverage Cash or cash equivalent $11.12 General
Category: Airway Clearance Therapy
09/13/2017 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $109.30 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/03/2017 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $81.30 General
Category: Cardiovascular
08/02/2017 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $9.29 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
07/20/2017 Abbott Laboratories FreeStyle Libre Pro (Device), FreeStyle Libre Pro, FreeStyle Libre Pro Food and Beverage In-kind items and services $19.81 General
Category: Diabetes Care
07/17/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $11.79 General
Category: NEUROSCIENCE
05/24/2017 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $17.85 General
Category: Critical Care
02/23/2017 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $11.92 General
Category: Urology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,005 1,796 $296,325 $70,233
2022 13 798 1,007 $175,621 $43,143
2021 13 1,652 2,034 $170,428 $72,109
2020 15 1,711 2,121 $143,163 $58,003
Total Patients
5,166
Total Services
6,958
Medicare Billing
$243,487
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 192 391 $70,380 $16,379 23.3%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 94 375 $69,375 $13,107 18.9%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 90 273 $30,030 $9,720 32.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 157 191 $25,785 $7,327 28.4%
90662 Influenza vaccine split virus, preservative free Office 2023 76 77 $8,470 $5,535 65.4%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 18 18 $9,450 $5,082 53.8%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2023 42 133 $11,970 $3,970 33.2%
G0008 Administration of influenza virus vaccine Office 2023 80 81 $3,078 $2,317 75.3%
91320 Sarscv2 vac 30mcg trs-suc im Office 2023 14 14 $4,046 $1,799 44.5%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 13 13 $3,510 $1,571 44.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 163 163 $44,825 $1,078 2.4%
99496 Transitional care management services for problem of high complexity Office 2023 17 18 $8,370 $859.80 10.3%
90480 Admn sarscov2 vacc 1 dose Office 2023 14 14 $1,260 $533.68 42.4%
G0009 Administration of pneumococcal vaccine Office 2023 17 17 $646.00 $486.20 75.3%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 18 18 $5,130 $467.02 9.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 183 339 $59,935 $13,580 22.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 174 212 $27,484 $8,536 31.1%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 28 28 $14,548 $7,808 53.7%
90662 Influenza vaccine split virus, preservative free Office 2022 65 66 $7,260 $4,517 62.2%
G0008 Administration of influenza virus vaccine Office 2022 68 69 $2,622 $1,861 71.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 13 13 $3,510 $1,786 50.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 163 163 $44,216 $1,123 2.5%
99496 Transitional care management services for problem of high complexity Office 2022 15 16 $7,200 $1,117 15.5%
G0009 Administration of pneumococcal vaccine Office 2022 32 32 $1,216 $866.52 71.3%
0054A Adm sarscv2 30mcg trs-sucr b Office 2022 17 17 $1,530 $611.42 40.0%

About Dr. Barry Wendt, MD

Dr. Barry Wendt, MD is a Specialist healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801888177.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Wendt, MD has received a total of $4,013 in payments from pharmaceutical and medical device companies, with $1,203 received in 2024. These payments were reported across 138 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,013).

As a Medicare-enrolled provider, Wendt has provided services to 5,166 Medicare beneficiaries, totaling 6,958 services with total Medicare billing of $243,487. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Internal Medicine, Internal Medicine
  • Location Crestview Hills, KY
  • Active Since 08/22/2005
  • Last Updated 08/19/2025
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1801888177

Products in Payments

  • ELIQUIS (Drug) $736.04
  • VRAYLAR (Drug) $335.46
  • BREZTRI (Drug) $232.40
  • Otezla (Drug) $200.61
  • Ozempic (Drug) $159.17
  • WATCHMAN (Device) $145.35
  • Veozah (Drug) $136.78
  • QULIPTA (Drug) $133.07
  • Cologuard Collection Kit (Device) $129.32
  • AIRSUPRA (Drug) $126.63
  • JARDIANCE (Drug) $119.30
  • FARXIGA (Drug) $117.86
  • LEQVIO (Drug) $80.79
  • UBRELVY (Drug) $59.02
  • XIFAXAN (Drug) $53.39
  • Saxenda (Drug) $52.44
  • Creon (Drug) $40.84
  • XARELTO (Drug) $39.23
  • VYVANSE (Drug) $38.86
  • Repatha (Biological) $34.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Crestview Hills